EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases

Parham Pooladgar iD, Mehdi Sakhabakhsh, Arsia Taghva iD, Saeed Soleiman-Meigooni iD

Iranian Journal of Pharmaceutical Research · 16.08.2022 · 21 (1)

DOI: 10.5812/ijpr-128408 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 16.08.2022. Verfasst von Parham Pooladgar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: Donepezil hydrochloride is an acetylcholine esterase inhibitor studied and approved to treat Alzheimer's disease (AD). However, this drug can have positive therapeutic potential in treating different conditions, including various neurodegenerative disorders such as other types of dementia, multiple sclerosis, Parkinson's disease, psychiatric and mood disorders, and even infectious diseases. Hence, this study reviewed the therapeutic potential of this drug in treating Alzheimer's and other diseases by reviewing the articles from databases including Web of Science, Scopus, PubMed, Cochrane, and Science Direct. It was shown that donepezil could affect the pathophysiology of these diseases via mechanisms such as increasing the concentration of acetylcholine, modulating local and systemic inflammatory processes, affecting acetylcholine receptors like nicotinic and muscarinic receptors, and activating various cellular signaling via receptors like sigma-1 receptors. Despite many therapeutic potentials, this drug has not yet been approved for treating non-Alzheimer's diseases, and more comprehensive studies are needed.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's DiseaseDonepezilInfectious DiseaseMental DisorderMultiple SclerosisParkinson's DiseaseSleep DisorderTraumatic Brain InjuryVascular Dementia

Autor:innen und Institutionen

  • Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Head of Department of Neurology, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran.
  • Department of Psychiatry, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran.
  • Infectious Diseases Research Center, Aja University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Parham Pooladgar, Arsia Taghva, Saeed Soleiman-Meigooni

Zitieren

APA

Pooladgar, P., Sakhabakhsh, M., Taghva, A., & Soleiman-Meigooni, S. (2022). Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases. Iranian Journal of Pharmaceutical Research, 21(1). https://doi.org/10.5812/ijpr-128408

Vancouver

Pooladgar P, Sakhabakhsh M, Taghva A, Soleiman-Meigooni S. Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases. Iranian Journal of Pharmaceutical Research. 2022;21(1). doi:10.5812/ijpr-128408

BibTeX
@article{Pooladgar2022,
  author = {Pooladgar, Parham and Sakhabakhsh, Mehdi and Taghva, Arsia and Soleiman-Meigooni, Saeed},
  title = {Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases},
  journal = {Iranian Journal of Pharmaceutical Research},
  year = {2022},
  volume = {21},
  number = {1},
  doi = {10.5812/ijpr-128408}
}
Kostenlos starten →